Reengineering Biologics Manufacturing And Access

by admin | Jan 24, 2022 | Press Release

Read more

From superfood to medicine maker, spirulina is a new cellular factory

by admin | Jan 17, 2022 | Press Release

Read more

Stopping a Global Killer, Lumen Bioscience takes Aim at Deadly Diarrheal Disease in Resource-Limited Settings

by admin | Jan 10, 2022 | Press Release

Read more

Lumen reversed logo Science Pipeline News About Careers Contact News Lumen Bioscience Releases Data on Potent, Orally Delivered Biologic Drug Cocktail for Preventing C. difficile Infection

by admin | Dec 22, 2021 | Press Release

– Preclinical data demonstrate LMN-201’s potential for preventing disease in at-risk patients — Lumen also announces successful Cohort 1 results in Phase 1 clinical trial Seattle, WA, December 23, 2021 – Lumen Bioscience, a clinical-stage biopharmaceutical...

Lumen Bioscience Partners with Leading Animal Health Company to Develop Oral Biologic Drugs and Reduce Antibiotic Use on Farms

by admin | Nov 3, 2021 | Press Release

Seattle, WA, November 3, 2021 – Lumen Bioscience, a clinical-stage biopharmaceutical company developing biologic drugs for highly prevalent diseases, today announced a research collaboration with a top-three animal health company to develop orally delivered biologic...

Lumen lands another DoD contract to treat Covid-related GI issues

by admin | Oct 8, 2021 | Press Release

Read more